Combination of dextromethorphan and bupropion for treating depression

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11229640
APP PUB NO 20210030749A1
SERIAL NO

17066310

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ANTECIP BIOVENTURES II LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Tabuteau, Herriot New York, US 513 29046

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 25, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 25, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 25, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00